stamaril powder and solvent for suspension for injection in prefilled syringe
sanofi pasteur. (0000010487) 14 espace henry vallee, lyon, 69007 - yellow fever virus,live attenuated,17d-204 strain - powder and solvent for suspension for injection in prefilled syringe - yellow fever virus,live attenuated,17d-204 strain (8000004019) 1000iu
stamaril in pre-filled syringe solution for injection
sanofi pasteur. (0000010487) 14 espace henry vallee, lyon, 69007 - yellow fever virus,live attenuated,17d-204 strain - solution for injection - in pre-filled syringe - yellow fever virus,live attenuated,17d-204 strain (8000004019) 1000dose(s) - yellow fever, live attenuated
stamaril ps.inj.sus 1000ld50 units / dose
ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ Βασ.Σοφίας 127,, 115 21 115 21, Αθήνα 6462281, 6430044 - yellow fever vaccine - ps.inj.sus (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 1000ld50 units / dose - yellow fever vaccine - yellow fever, live attenuated
stamaril ps.inj.sus 1000ld 50 units/dose
sanofi pasteur s.a., lyon, france 2, avenue pont pasteur, 69348 lyon cedex 07 - yellow fever vaccine - ps.inj.sus (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 1000ld 50 units/dose - yellow fever vaccine 1.000iu - yellow fever, live attenuated
avaxim 160 antigen units/0.5ml suspension for injection in pre-filled syringe
sanofi pasteur. (0000010487) 14 espace henry vallee, lyon, 69007 - hepatitis a virus (gbm strain) inactivated - suspension for injection in pre-filled syringe - 160 antigen units/0.5ml - hepatitis a virus (gbm strain) inactivated (8000003025) 160u - hepatitis a, inactivated, whole virus
dengvaxia
sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - Δάγκειος πυρετός - Εμβόλια - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 και 4. Η χρήση dengvaxia θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.
mmr-ii 5000tcid50/dose ly.pd.inj
vianex a.e. - measles, combinations with mumps and rubella, live attenuated - ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ - 5000tcid50/dose - ΕΜΒΟΛΙΑ
polyvar yellow 275 mg ενδοκυψελική ταινία
qp53ac05 - granted - bayer animal health gmbh - ectoparasiticide - activet ltd